Resumen de acción IART
Integra LifeSciences Holdings Corporation fabrica y vende instrumentos quirúrgicos, productos neuroquirúrgicos y productos para el cuidado de heridas destinados a neurocirugía, cuidados neurocríticos y otorrinolaringología.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Integra LifeSciences Holdings Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$25.08 |
| 52 Week High | US$50.78 |
| 52 Week Low | US$22.36 |
| Beta | 1.14 |
| 1 Month Change | -26.24% |
| 3 Month Change | -39.10% |
| 1 Year Change | -49.86% |
| 3 Year Change | -64.74% |
| 5 Year Change | -49.94% |
| Change since IPO | 442.27% |
Noticias y actualizaciones recientes
Recent updates
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 06FDA labels recall of intracranial pressure monitors by Integra as most serious
Aug 31Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance
Aug 24Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down
Aug 23Integra LifeSciences founder/former CEO dies
Aug 16Rentabilidad de los accionistas
| IART | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -14.0% | -0.5% | 1.6% |
| 1Y | -49.9% | -1.0% | 25.1% |
Rentabilidad vs. Industria: IART obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del -2%.
Rentabilidad vs. Mercado: IART obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| IART volatility | |
|---|---|
| IART Average Weekly Movement | 8.4% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de IART ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de IART (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1989 | 3,946 | Jan De Witte | www.integralife.com |
Integra LifeSciences Holdings Corporation fabrica y vende instrumentos quirúrgicos, productos neuroquirúrgicos y productos para el cuidado de heridas destinados a neurocirugía, cuidados neurocríticos y otorrinolaringología. Opera en dos segmentos, Codman Specialty Surgical y Tissue Technologies. La empresa ofrece productos de neurocirugía y cuidados neurocríticos, incluidos equipos de ablación tisular, productos de reparación dural, dispositivos de gestión del líquido cefalorraquídeo, equipos de monitorización intracraneal y equipos de estabilización craneal; y lámparas frontales e instrumentación quirúrgica, así como servicios posventa.
Resumen de fundamentos de Integra LifeSciences Holdings Corporation
| Estadísticas fundamentales de IART | |
|---|---|
| Capitalización bursátil | US$1.97b |
| Beneficios(TTM) | US$40.23m |
| Ingresos (TTM) | US$1.53b |
49.0x
Ratio precio-beneficio (PE)1.3x
Ratio precio-ventas (PS)¿Está IART sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IART | |
|---|---|
| Ingresos | US$1.53b |
| Coste de los ingresos | US$606.89m |
| Beneficio bruto | US$922.71m |
| Otros gastos | US$882.48m |
| Beneficios | US$40.23m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.51 |
| Margen bruto | 60.32% |
| Margen de beneficio neto | 2.63% |
| Ratio deuda/patrimonio | 106.0% |
¿Cómo se ha desempeñado IART a largo plazo?
Ver rendimiento histórico y comparativa